Polypharmacy and pattern of medication use among patients with gastroesophageal reflux disease: results from Pars Cohort study.

Arash Ghamar-ShooshtariZahra RahimianHossein PoustchiZahra MohammadiBita MesgarpourMohammadreza AkbariAlireza KamalipourSeyed Reza Abdipour-MehrianElham-Sadat HashemiPooria ZareKamran Bagheri LankaraniReza MalekzadehFatemeh MalekzadehHossein Molavi Vardanjani

Published in: BMC gastroenterology (2023)

GERD is correlated with a higher prevalence of polypharmacy. Among GERD patients, females, those with multi-morbidities, and those with metabolic syndrome may be affected more by polypharmacy. Considering the fairly high rate of interactions identified, a review of the medication list is essential when approaching GERD patients, and physicians must check for medications that may worsen GERD.

Keyphrases

gastroesophageal reflux disease
end stage renal disease
metabolic syndrome
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
primary care
healthcare
emergency department
adverse drug
skeletal muscle
adipose tissue
patient reported outcomes